SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ind-Swift Laboratories informs about disclosure

16 Jul 2021 Evaluate
Ind-Swift Laboratories has informed that in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (the SEBI Regulations), Code of Practices and Procedures for Prevention of Insider Trading and Code of Conduct & Fair Disclosure of Unpublished Price Sensitive Information (Company Code) and SEBI Circular No. SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020, the details of violation of the SEBI Regulations and Company Code by the Designated Person along with the action taken by the Company thereon is enclosed as ‘Annexure A’.

The above information is a part of company’s filings submitted to BSE.

Ind-Swift Lab. Share Price

132.00 -13.30 (-9.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×